Elanco Reports Full Year Earnings

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) is reporting a full-year net loss of $472 million in 2021, compared to a loss of $560 million the previous year. The company says full-year revenue was $4.7 billion, an increase of 46%.

Elanco also reports a fourth quarter net loss of $97 million, compared to $323 million during the same period a year earlier. Q4 revenue came in at $1.1 billion, a decrease of 2%.

“The fourth quarter of 2021 represents our 5th consecutive quarter of outperforming our expectations,” said Elanco President and Chief Executive Officer Jeff Simmons. “Our diverse portfolio delivered across the business – growing in all three regions and in four out of five species, demonstrating the durable growth profile of our business.”

Simmons expects the company to see two-to-three percent revenue growth. Click here to view the full report.